Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion clinical events and their risk factors

被引：0

作者：

Junichi Yoshida

Kenichiro Shiraishi

Tetsuro Tamura

Kazuhiro Otani

Tetsuya Kikuchi

Akiko Mataga

Takako Ueno

Masao Tanaka

机构：

[1] Infection Control Committee,Department of Medicine and Biosystemic Science

[2] Shimonoseki City Hospital,undefined

[3] Kyushu University Faculty of Medicine,undefined

来源：

Journal of Pharmaceutical Health Care and Sciences | / 8卷

关键词：

SARS-CoV-2; Casirivimab; Imdevimab; Fever; Hypoxia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用